Pyridostigmine Bromide Patent Expiration

Pyridostigmine Bromide was first introduced by Bausch Health Us Llc in its drug Mestinon on Approved Prior to Jan 1, 1982. Other drugs containing Pyridostigmine Bromide are Regonol, Pyridostigmine Bromide. 15 different companies have introduced drugs containing Pyridostigmine Bromide.


Pyridostigmine Bromide Patents

Given below is the list of patents protecting Pyridostigmine Bromide, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Pyridostigmine Bromide US10881617 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US10925833 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US10987311 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US11229606 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US11478425 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US11666536 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US11911515 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal
Pyridostigmine Bromide US12042559 Gastroretentive dosage forms for sustained drug delivery Jun 18, 2038 Amneal
Pyridostigmine Bromide US12233166 Extended release compositions comprising pyridostigmine Jun 18, 2038 Amneal



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pyridostigmine Bromide's patents.

Given below is the list recent legal activities going on the following patents of Pyridostigmine Bromide.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 25 Jul, 2025 US11229606
Email Notification 03 Mar, 2025 US12233166
Mail O.P. Petition Decision 03 Mar, 2025 US12233166
Mail-Petition Decision - Dismissed 26 Feb, 2025 US12233166
Petition Decision - Dismissed 25 Feb, 2025 US12233166
Patent eGrant Notification 25 Feb, 2025 US12233166
Recordation of Patent Grant Mailed 25 Feb, 2025 US12233166
Mail Patent eGrant Notification 25 Feb, 2025 US12233166
Email Notification 25 Feb, 2025 US12233166
Patent Issue Date Used in PTA Calculation 25 Feb, 2025 US12233166


Pyridostigmine Bromide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pyridostigmine Bromide Generic API Manufacturers

Several generic applications have been filed for Pyridostigmine Bromide. The first generic version for Pyridostigmine Bromide was by Solvay Pharmaceuticals and was approved on Nov 27, 1990. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Sep 21, 2023.

Given below is the list of companies who have filed for Pyridostigmine Bromide generic, along with the locations of their manufacturing plants worldwide.